New Key Statistics Module, Z-Score and F-Score
NEOE:LLY Key Ratios
Market Cap C$ M | 1,143,255.57 |
Enterprise Value C$ M | 1,177,920.57 |
P/E(ttm) | 115.15 |
PE Ratio without NRI | 80.63 |
Forward PE Ratio | 40.26 |
Price/Book | 62.08 |
Price/Sales | 21.69 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.23 |
Revenue (TTM) C$ M | 52,759.00 |
EPS (TTM) C$ | 0.30 |
Beneish M-Score | -1.65 |
10-y EBITDA Growth Rate % | 8.80 |
5-y EBITDA Growth Rate % | 10.70 |
y-y EBITDA Growth Rate % | 22.90 |
EV-to-EBIT | 90.21 |
EV-to-EBITDA | 77.25 |
PEG | 7.54 |
Shares Outstanding M | 33,009.17 |
Net Margin (%) | 18.86 |
Operating Margin % | 36.28 |
Pre-tax Margin (%) | 23.10 |
Quick Ratio | 0.87 |
Current Ratio | 1.11 |
ROA % (ttm) | 11.75 |
ROE % (ttm) | 61.77 |
ROIC % (ttm) | 25.06 |
Dividend Yield % | 0.42 |
Altman Z-Score | 9.96 |
NEOE:LLY Number of Guru Trades
NEOE:LLY Volume of Guru Trades
Gurus Latest Trades with NEOE:LLY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NEOE:LLY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Eli Lilly and Co Insider Transactions
No Available Data